Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with 99mTc-peptide-ZHER2:342

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

Cancer Statistics, Epidemiology, Cancer Epidemiology +14

Resistance to Trastuzumab in Breast Cancer

Paula R. Pohlmann, Ingrid A. Mayer, Ray Mernaugh · Clinical Cancer Research · 2009 · 495 citations · Full text

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

Peter Smith‐Jones, David B. Solit, Timothy Akhurst et al. · Nature Biotechnology · 2004 · 304 citations

Biochemistry, Her2 Degradation, Medicine +9

Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic ¹¹¹In- or ⁶⁸Ga-Labeled Affibody Molecules

Richard P. Baum, Vikas Prasad, Dirk Müller et al. · Journal of Nuclear Medicine · 2010 · 303 citations · Full text

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

Jamal Zidan, Igor Dashkovsky, Celina Stayerman et al. · British Journal of Cancer · 2005 · 279 citations · Full text